By 2060, new dementia cases per year could double to one million because of the growing population of older Americans, a ...

For many years, platinum-based chemotherapy has been one of the mainstays for advanced testicular cancer. Painful peripheral ...

The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

The evidence of gabapentin and dementia is mixed, with two studies looking at hundreds of thousands of people and coming to ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

Researchers at the University of Kentucky's Sanders-Brown Center on Aging are at the forefront of advancing dementia research ...

A new USC-led study suggests that assessing blood vessel health should be included in dementia diagnostics. A new USC-led ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.

Leqembi's subcutaneous dosing allows Alzheimer's patients to administer weekly treatment at home in 15 seconds ... with Mild ...

The lifetime risk of dementia after age 55 is about 42% - more than double the risk reported by earlier studies, and one that puts greater urgency on the need to mitigate addressable health problems, ...

Study Identifies Potential New Drug for Parkinson's-Related Cognitive Decline, Dementia Nov. 19 ... which could lead to treatments for the cognitive symptoms of Parkinson's ...